Industry Experts

Deep Shah is a regulatory strategist and biotechnology leader specializing in pushing the boundaries of cell and gene therapies. As Senior Director and Site Head at Sana Biotechnology, he translates complex genome engineering into viable clinical realities, guiding global regulatory and CMC pathways for pioneering iPSC-derived therapies. His fifteen-year track record spans impactful roles at Genentech, Allogene, and Lyell, where he has consistently calibrated corporate risk tolerance to safely accelerate first-in-class modalities. Backed by a Master’s in Regulatory Affairs from Northeastern University and a B.Pharm from Gujarat University, Deep bridges rigorous science with tactical vision to redefine modern drug development.